The Novo Nordisk Foundation is partnering with the Broad Institute of MIT and Harvard University to launch a massive genetic data mining project that aims to gain deeper insight into how human genetic variants affect risk for common complex diseases.
The U.S. Centers for Disease Control and Prevention said on Aug. 18 the CDC is creating a new disease forecasting center to improve the ability to use data to predict and gauge emerging health threats.
Coronavirus cases worldwide surpassed 200 million on Aug. 4, according to a Reuters tally, as the more-infectious Delta variant threatens areas with low vaccination rates and strains healthcare systems.
A record number of Americans died of drug overdoses during 2020 as pandemic lockdowns made getting treatment difficult and dealers laced more drugs with a powerful synthetic opioid, according to data released on July 14 and health officials.
Pfizer and partner BioNTech plan to ask U.S. and European regulators within weeks to authorize a booster dose of the companies’ Covid-19 vaccine, based on evidence of greater risk of infection six months after inoculation and the spread of the highly contagious Delta variant.
The World Health Organization said on Friday that it was not clear whether Covid-19 booster vaccines will be needed to maintain protection, until further data is collected.
The Olympics will take place without spectators in host city Tokyo, organizers said on July 8, as a resurgent coronavirus forced Japan to declare a state of emergency in the capital that will run throughout the Games.
World Health Organization emergencies head Michael Ryan urged countries on July 7 to use extreme caution when lifting Covid-19 restrictions so as “not to lose the gains you’ve made.”
New Delhi will start relaxing its strict coronavirus lockdown next week if new cases continue to drop in the city, the chief minister of India’s capital said on May 23.
Next year, people are likely to need an annual Covid-19 vaccination just like they need an annual flu shot. That prediction is made by researchers at six of Australia’s leading medical research institutions, based upon their study of the levels of neutralizing antibodies needed to confer protection against Covid-19.